KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Convertible Debt (2020 - 2026)

Guardant Health's Convertible Debt history spans 6 years, with the latest figure at $1.5 billion for Q4 2025.

  • On a quarterly basis, Convertible Debt rose 31.64% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 31.64% increase, with the full-year FY2025 number at $1.5 billion, up 31.64% from a year prior.
  • Convertible Debt hit $1.5 billion in Q4 2025 for Guardant Health, up from $1.1 billion in the prior quarter.
  • Over the last five years, Convertible Debt for GH hit a ceiling of $1.5 billion in Q4 2025 and a floor of $1.1 billion in Q3 2025.
  • Historically, Convertible Debt has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2022.
  • Biggest five-year swings in Convertible Debt: surged 40.75% in 2021 and later decreased 2.39% in 2025.
  • Tracing GH's Convertible Debt over 5 years: stood at $1.1 billion in 2021, then rose by 0.23% to $1.1 billion in 2022, then rose by 0.23% to $1.1 billion in 2023, then rose by 0.23% to $1.1 billion in 2024, then surged by 31.64% to $1.5 billion in 2025.
  • Business Quant data shows Convertible Debt for GH at $1.5 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.